"CD36 Antigens" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Leukocyte differentiation antigens and major platelet membrane glycoproteins present on MONOCYTES; ENDOTHELIAL CELLS; PLATELETS; and mammary EPITHELIAL CELLS. They play major roles in CELL ADHESION; SIGNAL TRANSDUCTION; and regulation of angiogenesis. CD36 is a receptor for THROMBOSPONDINS and can act as a scavenger receptor that recognizes and transports oxidized LIPOPROTEINS and FATTY ACIDS.
| Descriptor ID |
D018955
|
| MeSH Number(s) |
D12.776.157.530.300.500 D12.776.395.550.625.136 D12.776.543.550.625.136 D12.776.543.585.300.500 D12.776.543.750.011 D12.776.543.750.705.675.136 D12.776.543.750.705.940.625.249 D12.776.543.750.710.450.750.625.249
|
| Concept/Terms |
CD36 Antigens- CD36 Antigens
- Antigens, CD36
- Thrombospondin Receptor
- Receptor, Thrombospondin
- Receptors, Thrombospondin
- Thrombospondin Receptors
- OKM5 Antigen
- Antigen, OKM5
- Platelet Glycoprotein IV
- Glycoprotein IV, Platelet
- Platelet Membrane Glycoprotein IIIb
- Platelet Glycoprotein IIIb
- Glycoprotein IIIb, Platelet
- SR-BI Protein
- SR BI Protein
- Adipocyte Membrane Protein p88
- CD36 Fatty Acid Transporter
- FAT (Fatty Acid Translocase) - CD36 Antigen
- CD36 Antigen (Collagen Type I Receptor, Thrombospondin Receptor)
- GPIV Platelet Glycoprotein
- Platelet Glycoprotein, GPIV
- GPIIIb Platelet Glycoprotein
- Platelet Glycoprotein, GPIIIb
- Scavenger Receptors, Class B, Type I
- SR-BI Receptor
- Receptor, SR-BI
- SR BI Receptor
- CD36 Protein
- CD36 Antigen
- Antigen, CD36
- Platelet Membrane Glycoprotein IV
|
Below are MeSH descriptors whose meaning is more general than "CD36 Antigens".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Carrier Proteins [D12.776.157]
- Membrane Transport Proteins [D12.776.157.530]
- Fatty Acid Transport Proteins [D12.776.157.530.300]
- CD36 Antigens [D12.776.157.530.300.500]
- Glycoproteins [D12.776.395]
- Membrane Glycoproteins [D12.776.395.550]
- Platelet Membrane Glycoproteins [D12.776.395.550.625]
- CD36 Antigens [D12.776.395.550.625.136]
- Membrane Proteins [D12.776.543]
- Membrane Glycoproteins [D12.776.543.550]
- Platelet Membrane Glycoproteins [D12.776.543.550.625]
- CD36 Antigens [D12.776.543.550.625.136]
- Membrane Transport Proteins [D12.776.543.585]
- Fatty Acid Transport Proteins [D12.776.543.585.300]
- CD36 Antigens [D12.776.543.585.300.500]
- Receptors, Cell Surface [D12.776.543.750]
- CD36 Antigens [D12.776.543.750.011]
- Receptors, Immunologic [D12.776.543.750.705]
- Platelet Membrane Glycoproteins [D12.776.543.750.705.675]
- CD36 Antigens [D12.776.543.750.705.675.136]
- Receptors, Scavenger [D12.776.543.750.705.940]
- Scavenger Receptors, Class B [D12.776.543.750.705.940.625]
- CD36 Antigens [D12.776.543.750.705.940.625.249]
- Receptors, Lipoprotein [D12.776.543.750.710]
- Receptors, LDL [D12.776.543.750.710.450]
- Receptors, Scavenger [D12.776.543.750.710.450.750]
- Scavenger Receptors, Class B [D12.776.543.750.710.450.750.625]
- CD36 Antigens [D12.776.543.750.710.450.750.625.249]
Below are MeSH descriptors whose meaning is more specific than "CD36 Antigens".
This graph shows the total number of publications written about "CD36 Antigens" by people in this website by year, and whether "CD36 Antigens" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 2 | 0 | 2 |
| 2005 | 1 | 0 | 1 |
| 2006 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2013 | 2 | 0 | 2 |
| 2014 | 1 | 1 | 2 |
| 2015 | 1 | 1 | 2 |
| 2016 | 1 | 0 | 1 |
| 2017 | 0 | 3 | 3 |
| 2019 | 3 | 2 | 5 |
| 2021 | 1 | 0 | 1 |
| 2022 | 0 | 1 | 1 |
| 2024 | 0 | 1 | 1 |
| 2025 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "CD36 Antigens" by people in Profiles.
-
CD36-Mediated Metabolic Rewiring of Breast Cancer Cells Promotes Resistance to HER2-Targeted Therapies. Cell Rep. 2019 12 10; 29(11):3405-3420.e5.
-
Lymphocytes upregulate CD36 in adipose tissue and liver. Adipocyte. 2019 12; 8(1):154-163.
-
Letter by Wu and Ballantyne Regarding Article, "Protein Kinase C? via Activating Transcription Factor 2-Mediated CD36 Expression and Foam Cell Formation of Ly6Chi Cells Contributes to Atherosclerosis". Circulation. 2019 04 23; 139(17):2077-2078.
-
Effects of n-3 fatty acid treatment on monocyte phenotypes in humans with hypertriglyceridemia. J Clin Lipidol. 2017 Nov - Dec; 11(6):1361-1371.
-
Ca2+ Binding/Permeation via Calcium Channel, CaV1.1, Regulates the Intracellular Distribution of the Fatty Acid Transport Protein, CD36, and Fatty Acid Metabolism. J Biol Chem. 2015 Sep 25; 290(39):23751-65.
-
Foamy monocytes form early and contribute to nascent atherosclerosis in mice with hypercholesterolemia. Arterioscler Thromb Vasc Biol. 2015 Aug; 35(8):1787-97.
-
Proatherogenic conditions promote autoimmune T helper 17 cell responses in vivo. Immunity. 2014 Jan 16; 40(1):153-65.
-
CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation. Nat Immunol. 2013 Aug; 14(8):812-20.
-
Genome-wide association study indicates variants associated with insulin signaling and inflammation mediate lipoprotein responses to fenofibrate. Pharmacogenet Genomics. 2012 Oct; 22(10):750-7.
-
The role of angiocidin in sarcomas. Cancer. 2009 Nov 15; 115(22):5251-62.